High Impact Training to Patients with Prostate Cancer and Bone Metastases
Led by Copenhagen University Hospital at Herlev · Updated on 2025-02-13
102
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Researchers are evaluating the effects, safety, and feasibility of brief, high-impact exercise focused on bones in men with prostate cancer that has spread to the bones. This study aims to assess changes in bone health, body composition, physical function, quality of life, falls, hospitalizations, and the impact of resistance training on immune responses in blood and tumor tissue. The study is randomized and involves patients treated with hormone therapy for metastatic prostate cancer.
Participants in the intervention group will engage in a 32-week exercise program at the hospital, with supervised sessions twice a week lasting about 30 minutes each. The first eight weeks involve low-impact and bodyweight exercises to gradually learn movement patterns and use weight training equipment safely. Resistance exercises like deadlifts, overhead presses, and squats are then performed at high intensity for the remaining weeks. Blood samples and tumor biopsies will be collected during the study to analyze immune responses.
During the study, participants will undergo multiple assessments including lower body strength tests at baseline, 16, 32, and 44 weeks. Changes in body fat, muscle mass, bone mineral density, handgrip strength, fatigue, quality of life, physical activity, and safety events will be monitored throughout the study and for about one year. Hospitalizations, falls, and patient experiences will also be recorded. Immune responses will be specifically studied at several time points. This comprehensive monitoring helps understand how the exercise affects patients over time.
CONDITIONS
Brief Title
High Impact Training to Patients with Prostate Cancer and Bone Metastases
Who Can Participate
Age: 18Years +
MALE
Eligibility Criteria
You may qualify if you...
Patients with metastatic hormone sensitive prostate cancer (mHSPC)
Presence of bone metastases confirmed by recent imaging (Bone scan, CT, MRI, and/or PET)
Started androgen deprivation therapy less than 12 months ago; additional treatments like radiotherapy, novel hormone agents, or docetaxel allowed
Eastern Cooperative Oncology Group (ECOG) performance status score less than 2
Able to speak and read Danish and provide signed informed consent
Ambulatory without walking aids
You will not qualify if you...
Any physical condition that interferes with performing physical exercise training
Musculoskeletal, cardiovascular, or neurological conditions preventing exercise
Bone pain requiring opioid treatment
Planned or prior palliative radiation therapy to the bone
Major surgery within the past 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 32 weeks
Participants assigned to the intervention group participate in a 32-week, twice-weekly, 30-minute supervised high impact training program at the hospital. The first 8 weeks focus on self-bodyweight and low-impact exercises to learn movement patterns and transition safely to high-intensity resistance exercises performed at 80% to 85% of 1 repetition maximum.
Twice-weekly supervised sessions
Follow-up
Duration - Approximately 12 weeks after treatment
Participants are monitored for safety, physical function, quality of life, and immune responses up to approximately 12 weeks after the intervention ends, including assessments up to 44 weeks and qualitative evaluations up to 6 months after study completion.
1 to 2 visits at weeks 44 and up to 6 months post-study
High-intensity resistance and impact training for patients with hormone-sensitive prostate cancer and bone metastases-study protocol of a randomized clinical trial.
Anne-Mette Ragle, Marta Kramer Mikkelsen, Anders Vinther...